IPEC e-newsletter - Excipients Insight November 2017 - 22-11-17

 

Inside this issue

     

EMA makes decision on new location - it's Amsterdam!

As this edition of Excipients Insight went to press, the decision was made on the new location for the European Medicines Agency (EMA), with Amsterdam winning out over Milan by the narrowest of margins - picking the name out of a hat!

The first two voting rounds went to the Milan, but its Dutch rival won out in the third and decisive round by sheer chance after the EU ministers' final vote was tied. The city was also the most popular location among EMA staffers in a recent survey. The agency will relocate after the UK leaves the EU.

Ahead of the verdict, the agency issued a statement noting that it has less than 17 months to conclude its move and take up operations in the new host city by the end of March 2019. Copenhagen and Bratislava were also eliminated from the final shortlist.

“Moving a large organisation such as EMA to a new location is a challenging undertaking under any circumstances. It is made even more complex by the ambitious timetable determined by the withdrawal of the UK from the EU,” said the EMA in a statement.

The Council of the European Union has published a Q&A document on the main features of agencies’ relocation ahead of the final decision and announcement on 20 November.

Interestingly, there will be no permanent record of how Member States voted in the relocation process of the EMA and European Banking Authority (EBA), which is also leaving the UK as a result of Brexit. The decision to destroy ballot papers follows an agreement by EU leaders  that votes should be cast by secret vote.

 

 

 

Copyright © 2005 - 2017 IPEC Europe - International Pharmaceutical Excipients Council